Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Multicenter, Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

NCT03741127 is registered in ClinicalTrials.gov with Poseida Therapeutics, Inc. as lead sponsor.

NCT NCT03741127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03741127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Multicenter, Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
Lead sponsor
Poseida Therapeutics, Inc.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 29, 2018
Completion date
November 30, 2032
Enrollment
100 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma